Literature DB >> 26445315

Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.

Sophie Lardière-Deguelte, Louis de Mestier, François Appéré, Marie-Pierre Vullierme, Magaly Zappa, Christine Hoeffel, Marleny Noaves, Hedia Brixi, Olivia Hentic, Philippe Ruszniewski, Guillaume Cadiot, Yves Panis, Reza Kianmanesh.   

Abstract

INTRODUCTION: In patients with small intestinal neuroendocrine tumors (siNETs), surgical resection of the primary tumor and associated mesenteric lymph nodes (LNs) is recommended, but is not well standardized and can be risky in patients with superior mesenteric vessel involvement.
OBJECTIVE: We aimed to evaluate the correlation between the length of resected small bowel and the number of removed LNs, and to propose a preoperative morphological classification of siNET-associated LNs.
METHODS: The records of patients operated on for siNETs at two expert centers between August 2005 and November 2013 were analyzed. Two specialist radiologists reviewed the preoperative imaging and classified mesenteric LNs into five stages according to their proximity to the trunk and/or branches of the superior mesenteric artery.
RESULTS: 72 patients were included. The mean number of removed LNs was 12 ± 15 and the length of removed small intestine was 53 ± 43 cm. No correlation existed between the length of small bowel resection and the number of removed LNs. Overall, 9 (12%), 13 (18%), 36 (50%), 14 (19%) and 0 patients were classified into LN stages 0, I, II, III and IV. The correlation rate between the two observers was 0.98. Patients with LN stage III (hardly resectable) had more removed LNs than those with LN stages 0, I or II (easily removable).
CONCLUSION: Optimal lymphadenectomy is not always associated with extended small bowel resection. In the era of small bowel-sparing surgery, the preoperative classification of mesenteric LNs could help to standardize the surgical management of patients with siNETs.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26445315     DOI: 10.1159/000441423

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  14 in total

Review 1.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

Review 2.  [Surgical aspects of neuroendocrine tumors of the small intestine].

Authors:  F Weber; H Dralle
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 3.  How should incidental NEN of the pancreas and gastrointestinal tract be followed?

Authors:  Riccardo Ariotti; Stefano Partelli; Francesca Muffatti; Valentina Andreasi; Francesca Della Sala; Massimo Falconi
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 4.  How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery.

Authors:  Francesca Fermi; Valentina Andreasi; Francesca Muffatti; Stefano Crippa; Domenico Tamburrino; Stefano Partelli; Massimo Falconi
Journal:  Curr Oncol Rep       Date:  2022-01-25       Impact factor: 5.075

5.  An apparent primitive mass of the mesentery: A case report.

Authors:  Antonio Costanzo; Marco Canziani; Cesare Carlo Ferrari; Valentina Bertocchi; Saro Cutaia; Eraldo Oreste Bucci; Elisabetta Uslenghi; Andrea Ferretti; Marco De Luca; Fabio Ceriani
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

Review 6.  Workup of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Joseph S Dillon
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

7.  Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.

Authors:  Kosmas Daskalakis; Andreas Karakatsanis; Ola Hessman; Heather C Stuart; Staffan Welin; Eva Tiensuu Janson; Kjell Öberg; Per Hellman; Olov Norlén; Peter Stålberg
Journal:  JAMA Oncol       Date:  2018-02-01       Impact factor: 31.777

Review 8.  How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?

Authors:  Bruno Niederle; Andreas Selberherr; Martin B Niederle
Journal:  Curr Oncol Rep       Date:  2021-05-20       Impact factor: 5.075

Review 9.  Neuroendocrine Neoplasms of the Small Bowel and Pancreas.

Authors:  Ashley Kieran Clift; Mark Kidd; Lisa Bodei; Christos Toumpanakis; Richard P Baum; Kjell Oberg; Irvin M Modlin; Andrea Frilling
Journal:  Neuroendocrinology       Date:  2019-09-27       Impact factor: 5.135

10.  Multifocal neuroendocrine tumour of the small bowel presenting as an incarcerated incisional hernia: a surgical challenge in a high-risk patient.

Authors:  Kira Steinkraus; Julian R Andresen; Ashley K Clift; Marc O Liedke; Andrea Frilling
Journal:  J Surg Case Rep       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.